S L Wolden

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi request reprint American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI)
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021 6007, USA
    Am J Clin Oncol 36:97-101. 2013
  2. pmc Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, SM 17, New York, NY 10065, USA
    J Clin Oncol 30:3174-80. 2012
  3. ncbi request reprint Management of breast cancer after Hodgkin's disease
    S L Wolden
    Departments of Radiation Oncology, Medicine, and Surgery, Stanford University Medical Center, Stanford, CA, USA
    J Clin Oncol 18:765-72. 2000
  4. ncbi request reprint Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 64:57-62. 2006
  5. ncbi request reprint Radiation therapy for non-rhabdomyosarcoma soft tissue sarcomas in adolescents and young adults
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Pediatr Hematol Oncol 27:212-4. 2005
  6. ncbi request reprint Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 61:1432-8. 2005
  7. doi request reprint Sarcomas across the age spectrum
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Radiat Oncol 20:45-51. 2010
  8. ncbi request reprint Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 22, New York, NY 10021, USA
    J Clin Oncol 21:3079-83. 2003
  9. ncbi request reprint Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, SM07, New York, NY 10021, USA
    Cancer 97:179-85. 2003
  10. ncbi request reprint Brain-sparing radiotherapy for neuroblastoma skull metastases
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Pediatr Blood Cancer 50:1163-8. 2008

Detail Information

Publications51

  1. doi request reprint American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI)
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021 6007, USA
    Am J Clin Oncol 36:97-101. 2013
    ..This practice guideline can be part of ensuring quality and safety in a successful TBI program...
  2. pmc Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, SM 17, New York, NY 10065, USA
    J Clin Oncol 30:3174-80. 2012
    ..We present the long-term study outcome using final data through March 2007...
  3. ncbi request reprint Management of breast cancer after Hodgkin's disease
    S L Wolden
    Departments of Radiation Oncology, Medicine, and Surgery, Stanford University Medical Center, Stanford, CA, USA
    J Clin Oncol 18:765-72. 2000
    ..To evaluate the incidence, detection, pathology, management, and prognosis of breast cancer occurring after Hodgkin's disease...
  4. ncbi request reprint Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 64:57-62. 2006
    ..We now evaluate whether IMRT has resulted in improved outcomes for a larger cohort of patients with longer follow-up...
  5. ncbi request reprint Radiation therapy for non-rhabdomyosarcoma soft tissue sarcomas in adolescents and young adults
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Pediatr Hematol Oncol 27:212-4. 2005
    ..Results of anticipated cooperative group studies promise to guide future therapy for the various types of NRSTS...
  6. ncbi request reprint Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 61:1432-8. 2005
    ..To determine the preliminary results of intensity-modulated radiotherapy (IMRT) for head-and-neck rhabdomyosarcoma...
  7. doi request reprint Sarcomas across the age spectrum
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Radiat Oncol 20:45-51. 2010
    ..The other 2 are synovial sarcoma, which can be looked at as a bridge between pediatric and adult sarcomas as it affects mainly young adults, and liposarcoma that is almost exclusively an adult sarcoma...
  8. ncbi request reprint Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 22, New York, NY 10021, USA
    J Clin Oncol 21:3079-83. 2003
    ..To assess the patterns of failure for patients with medulloblastoma receiving a conformal tumor bed boost rather than a boost to the entire posterior fossa...
  9. ncbi request reprint Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, SM07, New York, NY 10021, USA
    Cancer 97:179-85. 2003
    ..The authors evaluated the outcome of patients with rhabdomyosarcoma (RMS) who were treated with three-dimensional (3D) conformal radiation therapy (RT) at a single institution...
  10. ncbi request reprint Brain-sparing radiotherapy for neuroblastoma skull metastases
    Suzanne L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Pediatr Blood Cancer 50:1163-8. 2008
    ..The purpose of this study was to describe the technique, outcome and toxicities in patients with high risk NB metastatic to the skull treated with brain-sparing skull radiotherapy (BSRT)...
  11. ncbi request reprint Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer
    S L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 46:859-64. 2000
    ..Nasopharynx cancer is a rare malignancy in childhood. This study aims to determine the role of chemotherapy, the optimal dose of radiation, and the long-term outcome for children with locoregional disease...
  12. ncbi request reprint Local control with multimodality therapy for stage 4 neuroblastoma
    S L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 46:969-74. 2000
    ..To evaluate the efficacy of 21 Gy hyperfractionated radiotherapy for local control in conjunction with surgery and intensive systemic therapy for patients with Stage 4 neuroblastoma...
  13. ncbi request reprint Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma
    S L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 19:1105-10. 2001
    ..To evaluate the feasibility and efficacy of concomitant boost radiotherapy (RT) plus cisplatin-based chemotherapy compared with standard fractionation RT for patients with advanced nasopharyngeal cancer...
  14. ncbi request reprint Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma
    S L Wolden
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 49:1229-34. 2001
    ..To determine whether the use of 3-dimensional (3D) boost for patients with nasopharynx cancer improves local control and reduces the risk of long-term complications...
  15. ncbi request reprint Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy
    Michelle L Klem
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
    Int J Radiat Oncol Biol Phys 70:1100-7. 2008
    ..With conventional techniques, significant toxicity can develop. Intensity-modulated radiotherapy (IMRT) has the potential to minimize the toxicity...
  16. ncbi request reprint Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 67:691-702. 2007
    ..To perform a retrospective analysis of patients with paranasal sinus (PNS) cancer treated with postoperative radiotherapy (RT) at Memorial Sloan-Kettering Cancer Center...
  17. doi request reprint Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 72:763-9. 2008
    ..To evaluate long-term outcomes and toxicity in patients with unresectable paranasal sinus carcinoma treated with radiotherapy, with or without chemotherapy...
  18. ncbi request reprint Results of multimodal treatment for desmoplastic small round cell tumors
    Dave R Lal
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Pediatr Surg 40:251-5. 2005
    ..4 years (range, 0.4-11.2 years). CONCLUSIONS: Multimodal therapy results in improved survival in patients with DSRCT. Aggressive surgical resection of these extensive intraabdominal neoplasms correlates with improved patient outcome...
  19. doi request reprint Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, New York 10021, USA
    Head Neck 30:925-32. 2008
    ....
  20. ncbi request reprint Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma
    William C Chen
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer 106:820-9. 2006
    ..The incidence and severity of sensorineural hearing loss (SNHL) with combined modality therapy was evaluated and the dose-response relation between radiation and hearing loss was investigated...
  21. ncbi request reprint Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era
    Trang H La
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 64:544-50. 2006
    ..To evaluate the outcomes of patients with Ewing's sarcoma family of tumors (ESFT) treated with modern radiotherapy techniques with MRI along with optimal chemotherapy...
  22. doi request reprint Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma
    Victoria J Croog
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Radiat Oncol Biol Phys 78:849-54. 2010
    ..This study describes the use of craniospinal irradiation (CSI) for CNS relapse and compares outcomes to patients who received focal radiotherapy (RT)...
  23. ncbi request reprint Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8
    Kim Kramer
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 25:5465-70. 2007
    ..We tested the toxicity, pharmacokinetics, and dosimetry of intraventricular iodine-131-labeled monoclonal antibody 3F8 (131I-3F8) targeting GD2-positive CNS/LM disease in a phase I clinical trial...
  24. ncbi request reprint Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:1365-72. 2008
    ..To analyze the recent experience of patients with adenoid cystic carcinoma treated with radiation therapy at Memorial Sloan-Kettering Cancer Center...
  25. ncbi request reprint A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 66:966-74. 2006
    ..intensity-modulated radiotherapy (IMRT) in the setting of concurrent chemotherapy (CT) for locally advanced oropharyngeal carcinoma...
  26. ncbi request reprint Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers
    Nancy Y Lee
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 69:459-68. 2007
    ..To perform a retrospective review of laryngeal/hypopharyngeal carcinomas treated with concurrent chemotherapy and intensity-modulated radiotherapy (IMRT)...
  27. doi request reprint Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience
    Stephanie A Terezakis
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 73:795-801. 2009
    ..External beam radiotherapy (EBRT) plays a controversial role in the management of nonanaplastic thyroid cancer. We reviewed our institution's outcomes in patients treated with EBRT for advanced or recurrent nonanaplastic thyroid cancer...
  28. doi request reprint Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 73:1096-103. 2009
    ..To present our single-institution experience of intensity-modulated radiotherapy (IMRT) for oral cavity cancer...
  29. doi request reprint Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer 115:2128-37. 2009
    ..The aim of the current study was to determine patterns of failure and adverse prognostic features...
  30. ncbi request reprint Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm
    David G Pfister
    Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 24:1072-8. 2006
    ..Cetuximab has activity in squamous cell carcinoma and enhances both chemotherapy and radiotherapy. We conducted a pilot phase II study of a new combined-modality paradigm of targeted therapy (cetuximab) with chemoradiotherapy...
  31. doi request reprint Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma
    Brian H Kushner
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 75:1181-6. 2009
    ..To present a large experience (73 patients) using a standard radiotherapy (RT) protocol to prevent relapse in cranial sites where measurable metastatic neuroblastoma (NB), an adverse prognostic marker, is common...
  32. pmc Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
    Kim Kramer
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 429, New York, NY 10065, USA
    J Neurooncol 97:409-18. 2010
    ..The cRIT-salvage regimen for CNS metastases was well tolerated by young patients, despite their prior history of intensive cytotoxic therapies. It has the potential to increase survival with better than expected quality of life...
  33. doi request reprint Radiotherapy after surgical resection for head and neck mucosal melanoma
    Abraham J Wu
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    Am J Clin Oncol 33:281-5. 2010
    ..To present our single-institution experience with postoperative radiotherapy for mucosal melanoma of the head and neck...
  34. doi request reprint Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma
    Ira J Dunkel
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Pediatr Blood Cancer 55:55-9. 2010
    ....
  35. ncbi request reprint Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experience
    Cherry L Estilo
    Dental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Pediatr Hematol Oncol 25:215-22. 2003
    ..To describe potential effects of multimodality therapy on dental and facial development in long-term survivors of head and neck rhabdomyosarcoma...
  36. ncbi request reprint Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer
    Benjamin D Rosenbluth
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 63:1419-26. 2005
    ..Intensity-modulated radiation therapy (IMRT) enables highly conformal treatment for thyroid cancer (TC). In this study, we review outcomes/toxicity in a series of TC patients treated with IMRT...
  37. ncbi request reprint Ureteral reconstruction for retroperitoneal tumors in children
    Daniel N Rutigliano
    Division of Pediatric Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Pediatr Surg 42:355-8. 2007
    ..Ureteral stricture can also be a result of intense therapy. We present our experience with urinary reconstruction in this situation...
  38. ncbi request reprint Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: a 10-year experience
    Karyn A Goodman
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Brachytherapy 2:139-46. 2003
    ..To evaluate the efficacy and toxicity of intraoperative high-dose-rate brachytherapy (IOHDR) in the management of pediatric solid tumors...
  39. ncbi request reprint Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV
    Jeff M Michalski
    Department of Radiation Oncology, Washington University School of Medicine, Box 8224, 4921 Parkview Place, Lower Level, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 59:1027-38. 2004
    ....
  40. ncbi request reprint Intensity-modulated radiotherapy
    Steven A Leibel
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer J 8:164-76. 2002
    ..The implementation of biologic evaluation of tumor sensitivity, in addition to methods that improve target delineation and dose delivery, represents a new dimension in intensity-modulated radiotherapy research...
  41. ncbi request reprint The challenging role of radiation therapy for very young children with rhabdomyosarcoma
    Dev R Puri
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 65:1177-84. 2006
    ..To evaluate local control and toxicity for very young children treated with multimodality therapy for rhabdomyosarcoma (RMS)...
  42. ncbi request reprint Symptomatic Chiari type I malformation after radiation therapy in an infant: case report
    Caitlin E Hoffman
    Department of Neurological Surgery, Weill Medical College of Cornell University, New York, New York 10021, USA
    Neurosurgery 60:E782; discussion E782. 2007
    ..The authors present an additional case of a 17-month-old girl treated for an isolated, malignant, rhabdoid tumor of the right neck with neoadjuvant chemotherapy, surgical exploration, and radiation therapy...
  43. ncbi request reprint PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools
    Michelle L Klem
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Pediatr Hematol Oncol 29:9-14. 2007
    ..Complete staging of rhabdomyosarcoma is critical to deliver appropriate therapy. We evaluated the role of F-fluorodeoxyglucose positron emission tomography (PET) in the staging of patients with rhabdomyosarcoma...
  44. ncbi request reprint Radiotherapy in the multimodal treatment of extrarenal extracranial malignant rhabdoid tumors
    Dev R Puri
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Pediatr Blood Cancer 50:167-9. 2008
    ..Our limited experience suggests that RT in the setting of CMT and surgery has the potential to prolong survival with acceptable toxicity, but outcomes are inconsistent and further study is necessary...
  45. ncbi request reprint Radiation-induced salivary gland tumors: a report of 18 cases and a review of the literature
    Kathryn P Beal
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cancer J 9:467-71. 2003
    ..The purpose of this study was to examine the relationship between radiation exposure and subsequent development of salivary gland tumors (SGTs)...
  46. ncbi request reprint The management of treatment-related esophageal complications in children and adolescents with cancer
    Dave R Lal
    Department of Surgery Pediatric Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Pediatr Surg 41:495-9. 2006
    ..Serious treatment-induced esophageal strictures and tracheoesophageal fistulae are rare in the pediatric oncology population. This report details our experience with their management...
  47. ncbi request reprint Nasopharyngeal carcinoma: recognizing the radiographic features in children
    Hilda E Stambuk
    Department of Radiology, Division of Neuroradiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    AJNR Am J Neuroradiol 26:1575-9. 2005
    ..The objective of this report is to emphasize that, although rare, nasopharyngeal carcinoma (NPC) does occur in children and can be diagnosed reliably when certain key radiographic features are recognized...
  48. ncbi request reprint Whole abdominopelvic radiotherapy for desmoplastic small round-cell tumor
    Karyn A Goodman
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 54:170-6. 2002
    ..Our objective was to evaluate the feasibility and outcome of whole abdominopelvic irradiation (WAPI) as part of a combined modality protocol for patients with DSRCT...
  49. ncbi request reprint Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy
    James B Nachman
    Section of Pediatric Hematology Oncology, University of Chicago, Chicago, IL, USA
    J Clin Oncol 20:3765-71. 2002
    ....
  50. ncbi request reprint Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study
    Enis Ozyar
    Hacettepe University, Oncology Institute, Ankara, Turkey
    Radiother Oncol 81:39-46. 2006
    ..This Rare Cancer Network (RCN) study was performed in pediatric nasopharyngeal carcinoma (PNPC) patients to evaluate the optimal dose of radiotherapy and to determine prognostic factors...
  51. ncbi request reprint Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Gr
    Megan Burke
    Children s Hospital Cleveland Clinic, Cleveland, USA
    J Clin Oncol 25:4909-13. 2007
    ..For Intergroup Rhabdomyosarcoma Study (IRS) IV patients with group III rhabdomyosarcoma, we assessed whether reported response assessed by anatomic imaging at week 8 predicted FFS...